Health Care & Life Sciences » Biotechnology | DNA Link Inc.

DNA Link Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
6,666
8,733
9,420
11,484
14,480
Cost of Goods Sold (COGS) incl. D&A
10,087
9,338
12,111
11,696
8,814
Gross Income
3,421
605
2,691
212
5,666
SG&A Expense
2,917
3,625
5,246
6,068
4,679
EBIT
6,346
4,253
7,965
6,342
944
Unusual Expense
-
-
509
2,105
5
Non Operating Income/Expense
7
47
344
20
631
Interest Expense
683
687
1,042
1,519
1,249
Pretax Income
6,835
4,819
9,103
9,821
339
Income Tax
376
360
49
60
1
Equity in Affiliates
-
-
-
51
-
Consolidated Net Income
7,211
4,459
9,054
9,811
338
Net Income
7,211
4,459
9,054
9,811
338
Net Income After Extraordinaries
7,211
4,459
9,054
9,811
338
Net Income Available to Common
7,211
4,459
9,054
9,811
338
EPS (Basic)
1,418.00
877.00
1,530.00
1,563.00
46.00
Basic Shares Outstanding
5
5
6
6
7
EPS (Diluted)
1,418.02
876.87
1,529.96
1,562.71
45.74
Diluted Shares Outstanding
5
5
6
6
7
EBITDA
4,399
1,674
4,968
3,277
2,743
Other Operating Expense
8
22
28
63
42
Non-Operating Interest Income
202
74
68
126
7

About DNA Link

View Profile
Address
2nd Floor, Cluster Center
Seoul SL 03760
Korea, Republic Of
Employees -
Website http://www.dnalink.com
Updated 09/14/2018
DNA Link, Inc. provides genomic analysis services. Its services include next generation sequencing, microarray, genotyping, patient-derived xenograft, AccuID, and DNA genomics personalized service. The company was founded on March 15, 2000 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.